← All Stocks

Aflac Incorporated

AFL · NYQ
$115.23+0.55%
52W Low: $105.4352W High: $130.22
Current: $115.23  ·  40% of 52-week range
Financial ServicesInsurance - LifeNYQ
View live charts, options flow & technicals for Aflac Incorporated → Open Dashboard

Aflac Incorporated (AFL) is a financial services company in the insurance - life industry with $18.07B in trailing revenue trading at a 12.4× trailing P/E — analyst consensus: hold.

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

Key Statistics

Market Cap$57.77B
Revenue (TTM)$18.07B
EPS (TTM)$9.32
EPS (Fwd est.)$7.54
Employees12,716
Trailing P/E12.36
Forward P/E15.28
PEG Ratio1.18
Price / Sales3.20
Price / Book1.91
EV / EBITDA10.72
Beta (5Y)0.58

Analyst Consensus

Consensus
Hold
Analyst Price Target
+2.9% upside
Target: $118.53

Annual Revenue & Net Income

RevenueNet Income
'22
$19.15B
$4.42B
'23
$18.84B
$4.66B
'24
$19.13B
$5.44B
'25
$17.36B
$3.65B

Earnings History


QuarterActual EPSEstimateResult
Aug 2026
$1.75
$1.76Miss (-0.5%)
Apr 2026
$1.75
$1.80Miss (-2.5%)
Feb 2026
$1.57
$1.69Miss (-7.3%)
Nov 2025
$2.49
$1.78Beat (+40.2%)

Next Earnings Report

Aflac Incorporated is next expected to report earnings on 04 Nov 2026.

Profitability

50.9%
25.7%
26.9%
Gross
Margin
Operating
Margin
Net
Margin
Revenue Growth (YoY)-1.0%
Return on Equity16.9%
Return on Assets3.1%

Balance Sheet

Cash & Equivalents$8.94B
Total Debt$16.18B
Net Position$7.24B (net debt)
Free Cash Flow (TTM)$5.15B
Debt / Equity53.37

Share Ownership

Institutions 60.1%
Insiders 10.9%
Public 29.0%

Dividend

Annual Rate
$2.44
Yield
2.13%
Payout Ratio
25.7%
Ex-Dividend Date
19 Aug 2026
5Y Avg Yield
2.16%

Frequently Asked Questions

What does Aflac Incorporated (AFL) do?
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, can…
What is AFL's market cap?
Aflac Incorporated has a market capitalization of approximately $57.77B.
What is AFL's P/E ratio?
Aflac Incorporated trades at a trailing P/E ratio of 12.4x and a forward P/E of 15.3x, which is below the broad market average of ~25x.
How much revenue does AFL generate?
Aflac Incorporated generated $18.07B in trailing 12-month revenue.
What do analysts say about AFL?
The analyst consensus rating for Aflac Incorporated is hold, with a mean price target of $118.53. That implies +2.9% upside from the current price.
When does AFL report earnings?
Aflac Incorporated is next scheduled to report earnings on 04 Nov 2026.
Does AFL pay a dividend?
Yes. Aflac Incorporated pays a dividend with a current yield of 2.13%, at an annual rate of $2.44 per share.

View live charts, options flow, gamma exposure, earnings history, and technical analysis for Aflac Incorporated on Apsis Markets.

Open Live Dashboard →